Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 26c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 26c

Jazz Pharmaceuticals (JAZZ) PT Raised to $206 at BMO Capital

August 8, 2018 7:00 AM EDT

BMO Capital raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $206.00 (from $201.00) while maintaining a Outperform rating.

Analsyt Gary Nachman commented, 'JAZZ reported a solid top and bottom line beat with 2Q revenue of $501mm vs. BMO/consensus $466mm/$470mm, and adj. EPS... More